Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study - Concepedia

Concepedia

Publication | Closed Access

Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study

36

Citations

33

References

2019

Year

Takeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, Masashi Namikawa, Hiroki Tojima, Yasushi Shimada, Daichi Takizawa, Atsushi Naganuma, Hirotaka Arai, Ken Sato,

Hepatology Research

Abstract

The Barcelona Clinic Liver Cancer intermediate stage was the predictive factor affecting the ORR and PFS, and ALBI grade was a good predictive factor affecting the incidence of fatigue and decreased appetite.

References

	Year	Citations

Page 1